Standards of Medical Care in Diabetes. Diabetes Care. 2019;42(1):S4-6.

Standards of Medical Care in Diabetes. Diabetes Care. 2017;40(1):S1-S135.

Neuropatias Diabéticas: Posicionamento da Associação Americana de Diabetes. 2019.

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care. 2018;41(1):S13-27.

IDF Diabetes Atlas. 2017.

Atlas do diabetes: atualização. 2019.

Pai YW, Lin CH, Lee IT, Chang MH. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus. Diabetes Metab Syndr. 2018;12(2):111-6.

Malta DC, Ducan BB, Schmidt MI, Machado IE, Da Silva AG, Bernal RTI. Prevalência de diabetes mellitus determinada pela hemoglobina glicada na população adulta brasileira, Pesquisa Nacional de Saúde. Rev Bras Epidemiol.. 2019;22(2).

Rolim LC, Koga da Silva EM, De Sá JR, Dib SA. A systematic review of treatment of painful diabetic neuropathy by pain phenotype versus treatment based on medical comorbidities. Front Neurol. 2017;8:285.

Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D. Neuropathic Pain Nat Rev Dis. Primers. 2017;16(3):17002.

Brod M, Pohlman B, Blum SI, Ramasamy A, Carson R. Burden of illness of diabetic's peripheral neuropathic pain: a qualitative study. Patient. 2015;8(4):339-48.

Goren A, Gross HJ, Fujii RK, Pandey A, Mould-Quevedo J. Prevalence of pain awareness, treatment, and associated health outcomes across different conditions in Brazil. Rev Dor. 2012;13(4):308-19.

Sacco ICN, Sartor CD, Gomes AA, João SMA, Cronfli R. Avaliação das perdas sensório-motoras do pé e tornozelo decorrente na neuropatia periférica. Rev Bras Fisoter. 2007;11(1):27-33.

King JB, Schauerhamer MB, Bellows BK. Review of the clinical study of duloxetina in the treatment of diabetic peripheral neuropathic pain. Ther Clin Risk Manag. 2015;11:1163-75.

Akuiz G, Kenis O. Physical therapy modalities and rehabilitation techniques in the management of neuropathic pain. Am J Phys Med Rehabil. 2014;93(3):253-9.

Souza JB, Carqueja CL, Baptista AF. Reabilitação física no tratamento de dor neuropática. Rev Dor. 2016;17(1):S85-90.

Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm,. 2008;17(4):758-64.

Bus SA, Valk GD, Van Deursen RW, Armstrong DG, Caravaggi C, Hlavácek P. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab Res Rev. 2008;24(1):S162-80.

Bus SA, Waaijman R, Arts M, de Haart M, Busch-Westbroek T, van Baal J. Effect of custom-made footwear on foot ulcer recurrence in diabetes a multicenter randomized controlled trial. Diabetes Care. 2013;36(12):4109-16.

Joanna Briggs Institute Reviewers' Manual: 2011 ed. .

Oxford Centre for evidence-based medicine levels of evidence. .

Sertbas M, Sertbas Y, Uner OZ, Elarslan S, Okuroglu N, Lens FAK. Autoflorescence ratio as noninvasive marker of peripheral diabetic neuropathy. Pol Arch Intern Med. 2019;129(3):175-80.

Alexander Jr J, Edwards RA, Brodsky M, Manca L, Grugni R, Savoldelli A. Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy. PLoS One. 2018;13(12).

Selvarajah D, Petrie J, White D. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. Trials. 2018;19(1):578.

Marcus J, Lasch K, Wan Y, Yang M, Hsu C, Merante D. An Assessment of clinically important differences on the worst pain severity item of the modified Brief Pain Inventory in patients with diabetic peripheral neuropathic pain. Pain Res Manag. 2018;2018:2140420.

Ahn AC, Bennani T, Freeman R, Hamdy O, Kaptchuk TJ. Two styles of acupuncture for treating painful diabetic neuropathy--a pilot randomised control trial. Acupunct Med. 2007;25(1-2):11-7.

Van Nooten F, Treur M, Pantiri K, Stoker M, Charokopou M. Capsaicin 8% patch versus oral neuropathic pain medications for the treatment of painful diabetic peripheral neuropathy: a systematic literature review and network meta-analysis. Clin Ther.. 2007;39(4):787-803.e18.

Garoushi S, Johson MI, Tashani OA. Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya. Libyan J Med. 2017;12(1):1384288.

Barbosa M, Saavedra A, Severo M, Maier C, Carvalho D. Validation and reliability of the Portuguese version of the Michigan Neuropathy Screening Instrument. Pain Pract. 2016;17(4):514-21.

Chevtchouk L, Silva MHSD, Nascimento OJMD. Ankle-brachial index and diabetic neuropathy: study of 225 patients. Arqu Neuropsiquiatr. 2017;75(8):533-8.

Salcini C, Atasever-Arslan B, Sunter G, Gur H, Isik FB, Saylan CC. High plasma pentraxin 3 levels in diabetic polyneuropathy patients with nociceptive pain. Tohoku J Exp Med. 2016;239(1):73-9.

Kelle B, Evran M, Balli T, Yavuz F. Diabetic peripheral neuropathy: correlation between nerve cross-sectional area on ultrasound and clinical features. J Back Musculoskelet Rehabil. 2016;29(4):717-22.

Hotta N, Kasuga M, Kashiwagi A, Kawamori R, Yamada T. Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: results from a randomized, 52-week, open-label study. J Diabetes Investig. 2016;7(1):100-8.

Papp GR, George MC, Dorfman D, Simpson DM. Barriers to chronic pain measurement: a qualitative study of patient perspectives. Pain Med. 2015;16(7):1256-64.

Mathieson S, Maher CG, Terwee CB, Folly de Campos T, Lin CW. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review. J Clin Epidemiol. 2015;68(8):957-66.

Gao Y, Guo X, Han P, Li Q, Yang G, Qu S. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo. Int J Clin Pract. 2015;69(9):957-66.

Bramson C, Herrmann DN, Carey W, Keller D, Brown MT, West CR. Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain. Pain Med. 2015;16(6):1163-76.

Kessler JA, Smith AG, Cha BS, Choi SH, Wymer J, Shaibani A. Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. Ann Clin Transl Neurol. 2015;2(5):465-78.

Celik S, Yenidunya , Temel E, Purisa S, Uzum AK, Gul N, Cinkil G. Utility of DN4 questionnaire in assessment of neuropathic pain and its clinical correlations in Turkish patients with diabetes mellitus. Prim Care Diabetes. 2016;10(4):259-64.

de Vos CC, Meier K, Zaalberg PB, Nijhuis HJ, Duyvendak W, Vesper J, Enggaard TP, Lenders MW. Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain. 2014;155(11):2426-31.

Agrawal RP, Jain S, Goyal S, Singhal S, Lindgren L, Sthengel E. A clinical trial of nitrosense patch for the treatment of patients with painful diabetic neuropathy. J Assoc Physicians India. 2014;62(5):385-90.

Dobrota VD, Hrabac P, Skegro D, Smiljanic R, Dobrota S, Prkacin I. The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes. Health Qual Life Outcomes.. 2014;3(12):171.

Freeman R, Baron R, Bouhassira D, Cabrera J, Emir B. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain. 2014;155(2):367-76.

Hamdan A, Luna JD, Del Pozo E, Galvez R. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population. Eur J Pain. 2014;18(1):101-9.

Pedras S, Carvalho R, Pereira MG. Caracteristicas sociodemograficas e clinicas de doentes com pe diabetico. Rev Assoc Med Bras. 2016;62(2):171-8.

Ziegler D, Schneider E, Boess FG, Berggren L, Birklein F. Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice. J Diabetes Complications. 2014;28(5):698-704.

Ajroud-Driss S, Christiansen M, Allen JA, Kessler JA. Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy. Mol Ther. 2013;21(6):1279-86.

Lee S, Kim JH, Shin KM, Kim JE, Kim TH, Kang KW. Electroacupuncture to treat painful diabetic neuropathy: study protocol for a three-armed, randomized, controlled pilot trial. Trials. 2013;18(14):225.

Spallone V, Morganti R, D'Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2013;29(5):578-85.

Walsh J, Rabey MI, Hall TM. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain. J Manipulative Physiol Ther. 2012;35(3):196-202.

Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012;26(5):424-9.

Adelmanesh F, Jalali A, Attarian H, Farahani B, Ketabchi SM, Arvantaj A. Reliability, validity, and sensitivity measures of expanded and revised version of the short-form McGill Pain Questionnaire (SF-MPQ-2) in Iranian patients with neuropathic and non-neuropathic pain. Pain Med. 2012;13(12):1631-6.

Searle RD, Bennett MI, Tennant A. Can neuropathic screening tools be used as outcome measures?. Pain Med. 2011;12(2):276-81.

Erbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients. J Clin Neurophysiol. 2011;28(1):51-5.

Abbott CA, Malik RA, Van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.. Diabetes Care. 2011;34(10):2220-4.

Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?. Pain. 2010;149(2):194-201.

Petrikonis K, Sciupokas A, Samusyte G, Janušauskaitė J, Sulcaite R, Vaitkus A. Importance of pain evaluation for more accurate diagnosis of painful diabetic polyneuropathy. Medicina. 2010;46(11):735-42.

Moreira RO, Amancio AP, Brum HR, Vasconcelos DL, Nascimento GF. Depressive symptoms and quality of life in type 2 diabetic patients with diabetic distal polyneuropathy. Arq Bras Endocrinol Metabol. 2009;53(9):1103-11.

Scherens A, Maier C, Haussleiter IS, Schwenkreis P, Vlckova-Moravcova E, Baron R. Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain. 2009;13(7):711-8.

Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3):S3-14.

Tavakoli M, Asghar O, Alam U, Petropoulos LN, Fadavi H, Malik RA. Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy. Ther Adv Endocrinol Metab. 2010;1(2):69-88.

Crawford B, Bouhassira D, Wong A, Dukes E. Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes. 2008;6:62.

Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med.. 2008:660-74.

Armstrong DG, Chappell AS, Le TK, Kajdasz DK, Backonja M, D'Souza DN. Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes. Pain Med. 2007;8(5):410-8.

Shillo P, Sloan G, Greig M, Hunt L, Selvarajah D, Elliott J. Painful and painless diabetic neuropathies: what is the difference?. Curr Diab Rep. 2019;19(6):32.

Barros GA, Coalhado OC, Giublin ML. Quadro clinico e diagnostico da dor neuropatica. Rev Dor. 2016;17(1):S15-9.

Barbosa M, Saavedra A, Severo M, Maier C, Carvalho D. Validation and reliability of the Portuguese version of the Michigan Neuropathy Screening Instrument. Pain Pract. 2016;17(4):514-21.

Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004;5(2):133-7.

Santos JG, Brito JO, De Andrade DC, Kaziyama VM, Ferreira KA, Souza I. Translation to Portuguese and validation of the Douleur Neuropathique 4 questionnaire. J Pain. 2011;11(5):484-90.

Schestatsky C, Felix-Torres V, Chaves ML, Camara-Ehlers B, Mucenic T, Caumo W. Brazilian Portuguese validation of the leeds assessment of neuropathic symptoms and signs for patients with chronic pain. Pain Med. 2011;12(10):1544-50.

Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R. A classification of chronic pain for ICD-11. Pain. 2015;6(156):1003-7.

Diagnosis and Classification of Neuropathic Pain. 2010;18(79).

Yang H, Sloan G, Ye Y, Wang S, Tesfaye S, Gao L. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol (Lausanne). 2020;17(10):929.

Casals-Vasquez C, Suarez-Cadena E, Estebanez Carvajal FM, Aguilar Trujillo MP, Jimenez Arcos MM, Vazquez Sachez MA. Relationship between quality of life, physical activity, nutrition, glycemic control and sarcopenia in older adults with type 2 diabetes mellitus. Nutr Hosp. 2017;34(5):1198-204.